Marinus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MARINUS, and what generic alternatives to MARINUS drugs are available?
MARINUS has one approved drug.
There are eight US patents protecting MARINUS drugs.
There are forty-three patent family members on MARINUS drugs in fifteen countries.
Drugs and US Patents for Marinus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 7,858,609 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 8,367,651 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 10,603,308 | ⤷ Sign Up | ⤷ Sign Up | ||||
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Marinus Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 4233861 | ⤷ Sign Up |
South Korea | 20080072760 | ⤷ Sign Up |
Spain | 2812250 | ⤷ Sign Up |
South Korea | 20120107533 | ⤷ Sign Up |
Canada | 2631233 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.